Literature DB >> 12193689

In situ analysis reveals physical interactions between CD11b+ dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen.

Elizabeth Ingulli1, Deborah R Ulman, Michelle M Lucido, Marc K Jenkins.   

Abstract

In situ staining techniques were used to visualize physical interactions between dendritic cell subsets and naive Ag-specific CD4 T cells in the lymph node. Before injection of Ag, CD8(+) dendritic cells and naive OVA-specific CD4 T cells were uniformly distributed throughout the T cell-rich paracortex, whereas CD11b(+) dendritic cells were located mainly in the outer edges of the paracortex near the B cell-rich follicles. Many OVA-specific CD4 T cells were in contact with CD8(+) dendritic cells in the absence of OVA. Within 24 h after s.c. injection of soluble OVA, the OVA-specific CD4 T cells redistributed to the outer paracortex and interacted with CD11b(+), but not CD8(+) dendritic cells. This behavior correlated with the uptake of OVA and the presence of peptide-MHC complexes on the surface of CD11b(+) dendritic cells, and subsequent IL-2 production by the Ag-specific CD4 T cells. These results are consistent with the possibility that CD11b(+) dendritic cells play a central role in the activation of CD4 T cells in response to s.c. Ag.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193689     DOI: 10.4049/jimmunol.169.5.2247

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node.

Authors:  Mark J Miller; Arsalan S Hejazi; Sindy H Wei; Michael D Cahalan; Ian Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-13       Impact factor: 11.205

Review 2.  An extended vision for dynamic high-resolution intravital immune imaging.

Authors:  Ronald N Germain; Flora Castellino; Marcello Chieppa; Jackson G Egen; Alex Y C Huang; Lily Y Koo; Hai Qi
Journal:  Semin Immunol       Date:  2005-10-10       Impact factor: 11.130

3.  In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles.

Authors:  Young Jik Kwon; Edward James; Nilabh Shastri; Jean M J Fréchet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

4.  MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo.

Authors:  Ursula B Fischer; Erica L Jacovetty; Ricardo B Medeiros; Brian D Goudy; Traci Zell; Jeannie-Beth Swanson; Elizabeth Lorenz; Yoji Shimizu; Mark J Miller; Alexander Khoruts; Elizabeth Ingulli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-13       Impact factor: 11.205

5.  Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.

Authors:  Ashley L St John; Cheryl Y Chan; Herman F Staats; Kam W Leong; Soman N Abraham
Journal:  Nat Mater       Date:  2012-01-22       Impact factor: 43.841

Review 6.  The lymph node at a glance - how spatial organization optimizes the immune response.

Authors:  Spencer M Grant; Meng Lou; Li Yao; Ronald N Germain; Andrea J Radtke
Journal:  J Cell Sci       Date:  2020-03-06       Impact factor: 5.285

7.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

Review 8.  Adaptive immunity to fungi.

Authors:  Marcel Wüthrich; George S Deepe; Bruce Klein
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

9.  Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells.

Authors:  Hai-Bin Wang; Ionita Ghiran; Klaus Matthaei; Peter F Weller
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

10.  MGL2 Dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo.

Authors:  Yosuke Kumamoto; Kaori Denda-Nagai; Satoshi Aida; Nobuaki Higashi; Tatsuro Irimura
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.